SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.57-0.8%Nov 3 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (1314)6/12/2002 9:01:11 PM
From: smh  Read Replies (2) of 1475
 
>>CHARLESTOWN, Mass.--(BUSINESS WIRE)--May 8, 2002--BioTransplant (Nasdaq: BTRN - news) today announced a cost reduction program in order to advance the Company's product lines while streamlining operations and reducing overall costs.
This program includes a reduction in workforce and spending cuts impacting all segments of the Company.

"These cost reduction measures are expected to conserve the needed resources to continue developing BioTransplant's promising product lines," commented Dr. Elliot Lebowitz, CEO of BioTransplant.

With these spending adjustments, BioTransplant expects to have operating capital for approximately three to four fiscal quarters. <<

That was just one month ago. What was the point? I assumed he was trying to buy time - waiting for a better opportunity - presumably following some overdue good news. Does this mean there will be no good news?

I don't see how the timing of the last two stock giveaways could possibly have been worse.

Disgusted
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext